Cisadane Sawit Raya Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Cisadane Sawit Raya Tbk trades at Rp760 (market cap 1.57T, 62.2K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Cisadane Sawit Raya Tbk is far larger — about 5.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 62.2K). Which is the better fit depends on your goals.
| CSRA | DGNS | |
|---|---|---|
Market Cap | 1.57T | 310.75B |
Volume | 62.2K | 963.6K |
Lot | 622 | 9.64K |
Turnover | 47.36M | 217.67M |
Average Price | 761.35 | 225.89 |
Value | 47.36M | 217.67M |
Indicative Equilibrium Price | 765 | 226 |
Indicative Equilibrium Volume | 100 | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cisadane Sawit Raya Tbk (the Company) was established based on Notarial Deed No. 82 dated October 28, 1983 of Public Notary Erly Soehandjojo, S.H., amended by Notarial Deed No. 107 dated November 25, 1987 of Public Notary H.Z. Simon, S.H.
Read more on CSRA →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →